Emmessar Biotech to hold AGM on Sept 29; reappoints MD, WTD

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Emmessar Biotech schedules its 34th AGM for September 29, 2026
  • Shareholders to reappoint MD Srinivasa Raghavan Mathurakavi Ayyangar for five years
  • WTD Jeyavel Balaiah Nadar seeks reappointment until February 2031
  • Remote e-voting opens on September 26 with a cutoff date of September 22
powered bylight_fuzz_icon
50075645

*this image is generated using AI for illustrative purposes only.

Emmessar Biotech has scheduled its 34th Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing or other audio-visual means, as permitted by Ministry of Corporate Affairs circulars.

The primary agenda involves the reappointment of key management personnel. Shareholders will vote on the five-year reappointment of Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director and Jeyavel Balaiah Nadar as Whole-time Director.

Management Reappointments

The Board proposes extending the tenure of Mr. Ayyangar from April 20, 2027, to April 19, 2032. His proposed monthly salary scale ranges from ₹2,20,000 to ₹4,00,000. Perquisites are capped at 50% of his salary and include housing, medical benefits, and club memberships.

Mr. Nadar’s reappointment covers the period from February 6, 2026, to February 5, 2031. His proposed salary scale is set between ₹1,20,000 and ₹2,50,000 per month. The resolution also seeks ratification of his acts and remuneration up to the date of the resolution.

Director Role Tenure Period Proposed Salary Scale (Monthly)
Srinivasa Raghavan Mathurakavi Ayyangar Managing Director April 20, 2027 – April 19, 2032 ₹2,20,000 – ₹4,00,000
Jeyavel Balaiah Nadar Whole-time Director February 6, 2026 – February 5, 2031 ₹1,20,000 – ₹2,50,000

Governance and Voting

Mr. Jeyavel Balaiah Nadar also retires by rotation and offers himself for re-appointment as a Director. The company confirmed compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, by sending separate letters to shareholders without registered email addresses.

Remote e-voting will commence on September 26, 2026, at 9:00 am and conclude on September 28, 2026, at 5:00 pm. The record date for voting rights is September 22, 2026. Institutional shareholders must upload board resolutions authorizing their representatives to vote.

Historical Stock Returns for Emmessar Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-3.72%-2.96%-3.76%-6.06%-13.37%0.0%

How might the five-year tenure extension for the Managing Director influence Emmessar Biotech's long-term strategic roadmap and R&D pipeline stability?

What is the market's likely reaction to the proposed salary scales for key management, particularly in comparison to peer companies in the biotech sector?

Could the reappointment of Jeyavel Balaiah Nadar signal any upcoming shifts in corporate governance or operational focus for the company?

Emmessar Biotech sets 34th AGM for September 29 via video conferencing

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Emmessar Biotech schedules its 34th AGM for September 29, 2026
  • The meeting will be held via video conferencing starting at 10:30 am
  • Notices and annual reports for FY26 are sent electronically only
  • Shareholders must register email IDs with RTA or DP to access documents
powered bylight_fuzz_icon
49368475

*this image is generated using AI for illustrative purposes only.

Emmessar Biotech & Nutrition Ltd has scheduled its 34th Annual General Meeting for September 29, 2026. The event will be conducted through video conferencing and other audio-visual means.

The meeting is set to begin at 10:30 am on Tuesday. The company issued the notice in compliance with Ministry of Corporate Affairs circulars and SEBI listing regulations. These guidelines permit holding meetings remotely and distributing documents electronically.

Shareholder Instructions

Shareholders will receive the AGM notice and annual report for FY26 only through electronic mode. This applies exclusively to members who have registered their email addresses with the Registrar and Share Transfer Agent or Depository Participant.

Investors without registered email IDs must update their details to participate. They can do so by logging into the MUFG Intime India Private Limited website under Investor Services. Alternatively, demat account holders should contact their Depository Participant directly.

Voting and Accessibility

E-voting login details will be sent to registered email addresses. The AGM notice will also be available on the company website and the stock exchange portal. Members can attend and vote using the video conferencing facility provided.

What the Numbers Show

The reliance on electronic communication highlights a shift toward digital shareholder engagement. By restricting physical copies to those without registered emails, the company streamlines its distribution process while maintaining regulatory compliance.

Historical Stock Returns for Emmessar Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-3.72%-2.96%-3.76%-6.06%-13.37%0.0%

How might Emmessar's strict digital-only AGM policy impact participation rates among older or less tech-savvy shareholders?

What are the potential cybersecurity risks associated with holding the entire AGM and voting process remotely, and how is the company mitigating them?

Could this shift to fully electronic communication signal a broader trend in Indian biotech firms reducing operational costs through digital transformation?

More News on Emmessar Biotech

1 Year Returns:-13.37%